13F-HR filed by Broadfin Capital, LLC
Broadfin Capital, LLC filed this 13F-HR for the quarter ended 2017-12-31, filed 2018-02-13, with 46 holding rows worth $611,753,000.
- Accession
- 0001511901-18-000002
- Filer
- CIK 1511901
- Filed
- 2018-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2017
A holdings report, 46 entries on the cover page, a total value of $611,753,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $611,753,000 with VALUE read as thousands by filing date, 13F file number 028-14251. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerBroadfin Healthcare Master Fund Ltd 028-14254
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 2,447,746 | $44,671,000 | thousands by filing date | |
| HORIZON PHARMA PLC | G4617B105 | SHS | 3,018,021 | $44,063,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 2,028,518 | $36,716,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 1,641,868 | $34,594,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 1,029,866 | $33,141,000 | thousands by filing date | |
| CORIUM INTL INC | 21887L107 | COM | 3,432,326 | $32,985,000 | thousands by filing date | |
| IGNYTA INC | 451731103 | COM | 1,150,119 | $30,708,000 | thousands by filing date | |
| ANGIODYNAMICS INC | 03475V101 | COM | 1,732,361 | $28,809,000 | thousands by filing date | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 7,097,300 | $27,750,000 | thousands by filing date | |
| STRONGBRIDGE BIOPHARMA PLC | G85347105 | SHS USD | 3,186,695 | $23,104,000 | thousands by filing date | |
| ARATANA THERAPEUTICS INC | 03874P101 | COM | 4,294,426 | $22,589,000 | thousands by filing date | |
| SOCIETAL CDMO INC | 75629F109 | COM | 2,436,025 | $22,533,000 | thousands by filing date | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 2,591,721 | $21,252,000 | thousands by filing date | |
| ENDO INTL PLC | G30401106 | SHS | 2,442,323 | $18,928,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 2,340,611 | $18,725,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 457,080 | $18,306,000 | thousands by filing date | |
| GW PHARMACEUTICALS PLC | 36197T103 | ADS | 122,930 | $16,228,000 | thousands by filing date | |
| INTEGRA LIFESCIENCES HLDGS C | 457985208 | COM NEW | 330,600 | $15,823,000 | thousands by filing date | |
| BIODELIVERY SCIENCES INTL IN | 09060J106 | COM | 4,634,119 | $13,671,000 | thousands by filing date | |
| MEDICINES CO | 584688105 | COM | 366,300 | $10,015,000 | thousands by filing date | |
| ANTARES PHARMA INC | 036642106 | COM | 4,535,647 | $9,026,000 | thousands by filing date | |
| NATUS MEDICAL INC | 639050103 | COM | 204,400 | $7,808,000 | thousands by filing date | |
| PARATEK PHARMACEUTICALS INC | 699374302 | Equity | 406,207 | $7,271,000 | thousands by filing date | |
| TELIGENT INC NEW | 87960W104 | COM | 1,925,415 | $6,989,000 | thousands by filing date | |
| NOVELION THERAPEUTICS INC | 67001K202 | COM NEW | 1,948,554 | $6,079,000 | thousands by filing date | |
| PERNIX THERAPEUTICS HLDGS IN | 71426VAK4 | DBCV 4.250 4/0 | 15,000,000 | $5,989,000 | thousands by filing date | |
| CIDARA THERAPEUTICS INC COM NEW | 171757107 | Stock | 857,397 | $5,830,000 | thousands by filing date | |
| TETRAPHASE PHARMACEUTICALS INC | 88165N105 | COMMON STOCK | 889,100 | $5,601,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 746,358 | $4,874,000 | thousands by filing date | |
| NUVASIVE INC | 670704105 | COM | 82,100 | $4,802,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 1,150,449 | $4,613,000 | thousands by filing date | |
| HORIZON PHARMA PLC | G4617B105 | SHS | 300,000 | $4,380,000 | thousands by filing date | call |
| IDERA PHARMACEUTICALS INC | 45168K306 | COM | 2,030,604 | $4,285,000 | thousands by filing date | |
| BAXTER INTL INC | 071813109 | COM | 65,300 | $4,221,000 | thousands by filing date | |
| ADMA BIOLOGICS INC | 000899104 | COM | 1,102,200 | $3,538,000 | thousands by filing date | |
| MEDIWOUND LTD | M68830104 | ORD SHS | 500,000 | $2,225,000 | thousands by filing date | |
| COGENTIX MED INC COM | 19243A104 | Stock | 670,812 | $2,113,000 | thousands by filing date | |
| REGULUS THERAPEUTICS INC | 75915K101 | COM | 1,509,342 | $1,570,000 | thousands by filing date | |
| CONTRAFECT CORP | 212326102 | COM | 1,231,666 | $1,244,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 51,900 | $1,094,000 | thousands by filing date | call |
| AGILE THERAPEUTICS INC | 00847L100 | COM | 358,295 | $964,000 | thousands by filing date | |
| OVASCIENCE INC | 69014Q101 | COM | 550,000 | $770,000 | thousands by filing date | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 100,000 | $747,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 86,558 | $472,000 | thousands by filing date | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 145,514 | $387,000 | thousands by filing date | |
| STRATA SKIN SCIENCES INC | 86272A206 | COMMON | 203,346 | $250,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001511901-18-000002 | this filing | 2018-02-13 | acceptance time not in the bulk data set |